Close

Analyst Ratings for Marrone Bio Innovations (MBII)

MBII Rating Summary

  |   Expand Research on MBII
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.3 / 10   Percentile Rank: 67%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/17/2022 Canaccord Genuity Bobby Burleson Downgrade Hold
(Buy)
1.30
(N/A)
0.70
(0.80)
14.29% Details
9/22/2021 Roth/MKM Gerry Sweeney New Coverage Buy
(N/A)
2.00
(N/A)
0.82
(0.80)
-2.44% Details